First Financial Equity Corporation’s Novartis NVS Stock Holding History

First Financial Equity Corporation’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$1.82M	Buy	+27,086	New	+$1.8M	0.31%	95

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

First Financial Equity Corporation's NVS Position: Q1 2017 in Review

First Financial Equity Corporation opened a new position in Novartis (NVS) in Q1 2017: 27,086 shares worth $1.82M. The stake represents 0.31% of the portfolio and ranks #95 among its holdings.

909 funds tracked by Wall St. Rank hold NVS as of Q1 2017.

First Financial Equity Corporation held 27,086 shares of Novartis worth $1.82M as of Q1 2017.
Novartis was a new First Financial Equity Corporation position in Q1 2017.
Novartis made up 0.31% of First Financial Equity Corporation's portfolio in Q1 2017, its #95 holding.
909 funds tracked by Wall St. Rank held Novartis as of Q1 2017.

Based on First Financial Equity Corporation's 13F filing for Q1 2017, filed 16 May 2017.